These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19745251)

  • 1. The PSIP approach to account for human factors in Adverse Drug Events: preliminary field studies.
    Riccioli C; Leroy N; Pelayo S
    Stud Health Technol Inform; 2009; 148():197-205. PubMed ID: 19745251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A knowledge engineering framework towards clinical support for adverse drug event prevention: the PSIP approach.
    Koutkias V; Stalidis G; Chouvarda I; Lazou K; Kilintzis V; Maglaveras N
    Stud Health Technol Inform; 2009; 148():131-41. PubMed ID: 19745243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human factors engineering for computer-supported identification and prevention of adverse drug events.
    Beuscart-Zéphir MC; Nøhr C
    Stud Health Technol Inform; 2009; 148():14-24. PubMed ID: 19745231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factors methods to support the experts' review of automatically detected adverse drug events.
    Leroy N; Bjørn B; Baceanu A; Beuscart-Zephir MC
    Stud Health Technol Inform; 2009; 150():542-6. PubMed ID: 19745370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of human factors for the review of automatically detected ADE.
    Leroy N; Luyckx M; Lecocq P; Marcilly R; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2009; 148():170-80. PubMed ID: 19745248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient safety through intelligent procedures in medication: the PSIP project.
    Beuscart R; McNair P; Brender J;
    Stud Health Technol Inform; 2009; 148():6-13. PubMed ID: 19745230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three different cases of exploiting decision support services for adverse drug event prevention.
    Bernonille S; Nies J; Pedersen HG; Guillot B; Maazi M; Berg AL; Sarfati JC; Koutkias V
    Stud Health Technol Inform; 2011; 166():180-8. PubMed ID: 21685623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Human Factors in an international research project: lessons learned from the PSIP project.
    Marcilly R; Beuscart-Zephir MC; Beuscart R
    Stud Health Technol Inform; 2013; 183():162-7. PubMed ID: 23388275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of completeness, correctness, relevance and understandability of the PSIP CDSS for medication safety.
    Ammenwerth E; Hackl WO; Massari P; Darmoni S
    Stud Health Technol Inform; 2011; 166():254-9. PubMed ID: 21685631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication related computerized decision support system (CDSS): make it a clinicians' partner!
    Marcilly R; Leroy N; Luyckx M; Pelayo S; Riccioli C; Beuscart-Zéphir MC
    Stud Health Technol Inform; 2011; 166():84-94. PubMed ID: 21685614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient safety: detection and prevention of adverse drug events.
    Beuscart R; McNair P; Darmoni SJ; Koutkia V; Maglaveras N; Beuscart-Zephir MC; Nohr C;
    Stud Health Technol Inform; 2009; 150():968-71. PubMed ID: 19745457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scorecards: a new method to prevent adverse drug events? Preliminary results from a clinical field study.
    Marcilly R; Hackl WO; Luyckx M; Ammenwerth E
    Stud Health Technol Inform; 2011; 166():234-45. PubMed ID: 21685629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug event prevention in neonatal care: a rule-based approach.
    Lazou K; Farini M; Koutkias V; Drossou V; Maglaveras N; Bassiliades N
    Stud Health Technol Inform; 2013; 186():170-4. PubMed ID: 23542991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing, implementing and evaluating e-prescription: a field study and comparison with PSIP results.
    Riccioli C; Cacciabue PC; Campanini M; Jung M
    Stud Health Technol Inform; 2011; 166():105-15. PubMed ID: 21685616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing adverse drug events in hospital practice: an overview.
    Rommers MK; Teepe-Twiss IM; Guchelaar HJ
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1129-35. PubMed ID: 17610221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a standardised representation of a knowledge base for adverse drug event prevention.
    Koutkias V; Lazou K; de Clercq P; Maglaveras N
    Stud Health Technol Inform; 2011; 166():139-47. PubMed ID: 21685619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-mining-based detection of adverse drug events.
    Chazard E; Preda C; Merlin B; Ficheur G; ; Beuscart R
    Stud Health Technol Inform; 2009; 150():552-6. PubMed ID: 19745372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.